Back from hiatus, Anish and Dr. DiGiorgio swap travel notes on Japan and San Diego before diving into Anish's recent Substack piece mapping emergency cardiac care access across the United States — where 98% of Americans live within 90 minutes of a PCI-capable hospital, a level of coverage no peer country (including Canada) comes close to matching. They extend the analysis to thrombectomy-capable stroke centers, trauma coverage, and what it really means when the Commonwealth Fund ranks the US last. The conversation turns to whether the "rural healthcare crisis" narrative justifies continued subsidies (critical access designation, 340B, DISH payments, the new OBBA rural fund) or simply props up a monopoly structure that blocks physician-owned hospitals and ASCs. They unpack Mark Cuban's HSA-plus-catastrophic-coverage proposal, its blind spots on chronic illness and supply-side cost, the two-midnight rule lawsuit between Jefferson and Aetna, cost-plus reimbursement grandfathering, and how CMS's new "efficiency adjustment" has made it financially rational for neurosurgeons to hand off post-op critical care — inadvertently telling the origin story of neurocritical care as a specialty. They close with the new CDC director announcement and a look ahead to next week's guest, Dr. Elad Levy.

00:00 Back from hiatus — Japan, San Diego, and American public transit

03:45 Happy tax day and the Bay Area commute problem

04:45 Anish's Substack piece: mapping PCI access across America

07:50 Why PCI capability is the right proxy for emergency care infrastructure

10:00 Building the map — counties, census tracts, and the 90-minute door-to-balloon window

14:30 98% coverage: the US vs Canada, Russia, China

18:24 Thrombectomy-capable stroke centers and the 60-minute brain window

22:07 What do you actually want from a healthcare system?

27:12 The original sin of Medicare and the employer tax exemption

30:13 Rural hospital subsidies: critical access, 340B, DISH, and the OBBA rural fund

37:02 Physician-owned hospitals, Stark Law, and ASCs as an alternative model

40:30 Mark Cuban's HSA plan: stop-loss, direct primary care, and the $2,100 family premium

44:13 Extending the idea to Medicaid — wealth accrual and the 100% benefit cliff

46:31 The chronic illness problem and federal reinsurance as a backstop

47:57 The missing piece: supply-side deregulation and lowering cost of care

50:19 Jefferson sues Aetna: the two-midnight rule and who the real villain is

53:04 UCR, cost-plus reimbursement, and the hospitals still grandfathered in

55:37 The CMS efficiency adjustment and the neurosurgeon's 8-day break-even

58:45 The origin story of neurocritical care as a specialty

01:02:16 New CDC director Erica Schwartz and next week's guest Dr. Elad Levy

@anish_koka and @drdigiorgio

@drsloungepod

Resources:

Quantifying the Rural Access Problem: Emergency Cardiac Care as a Window into American Healthcare — https://anishkokamd.substack.com/p/quantifying-the-rural-access-problem

America Has Solved the Hardest Healthcare Access Problem Better Than Anyone Else — Here's the Data — https://anishkokamd.substack.com/p/the-us-healthcare-system-has-basically

Interactive PCI Access Maps (US & Canada) — https://anishkoka.github.io/pci-access-maps/

YouTube: https://www.youtube.com/@TheDoctorsLounge

Episode Summary

Dr. DiGiorgio returns from testifying before the House Energy and Commerce Subcommittee on Health, the third in a series of hearings on healthcare costs covering the provider landscape. The two break down the major policy levers discussed in his testimony — site-neutral payment, Stark Law reform, physician-owned hospitals, and Certificate of Need laws — and why so many obviously good solutions remain politically untouchable. They also dig into the rural access gap, the failure of the NP independence experiment to solve it, Medicare Advantage risk adjustment, and the new HHS healthcare advisory committee. As always, the diagnosis is clear; the politics are the hard part.

Chapter Markers

0:00 – Welcome back & Dr. DiGiorgio's Congressional testimony

3:16 – Site-neutral payment: why everyone knows it's right and no one acts

6:26 – You can't do site neutrality without also enabling competition

8:20 – How MedPAC's methodology actually works

11:50 – Stark Law explained — and why it creates a double standard

14:32 – Hospice fraud, Armenian gangs, and Nick Shirley

20:30 – The original sin: third-party payment and utilization control

23:52 – The case for allowing physician referral networks

25:15 – Hospitals' self-referral hypocrisy and the Federation of American Hospitals tweet

28:52 – How Section 6001 of the ACA banned physician-owned hospitals

30:13 – The new HHS healthcare advisory committee — will it matter?

37:44 – The rural access gap: how big is the problem really?

42:52 – Why NP independence didn't solve rural shortages

47:58 – International medical graduates and the rural fiction

50:06 – Let prices rise: the market solution to rural primary care

55:25 – Medicaid federal matching rates and state competitiveness

56:38 – How Democrats and Republicans engaged at the hearing

58:57 – The politics of why nothing gets done

Links:

YouTube Dr. Digiorgio Congressional Testimony: https://www.youtube.com/watch?v=sjPr3fK9jjc

Written Testimony

@anish_koka | @drdigiorgio

@drsloungepod

🎧 Spotify | Apple Podcasts | YouTube

Kevin Bass, PhD, joins Anish and Dr. DiGiorgio to tell the story of how a viral Newsweek op-ed apologizing for his support of COVID lockdowns and mandates set off a chain of events that ended in his dismissal from Texas Tech's MD/PhD program. Kevin walks through the internal emails, sham professionalism hearings, and rigged dismissal process he uncovered through FERPA records requests — and his ongoing federal and state lawsuits alleging First Amendment retaliation. The conversation then shifts to what Kevin has been building since: using AI pipelines to do large-scale investigative data analysis, from parsing the Epstein files to probing Medicaid fraud — work he argues would have taken a newsroom months, done now in days by one person.

YouTube Chapters:

00:00 - Introduction and Kevin Bass background

01:16 - Kevin's COVID arc: from establishment supporter to dissenter

03:14 - The Newsweek op-ed and Tucker Carlson appearance

08:00 - Internal emails and the professionalism complaint campaign

13:44 - Sham hearings, appeals, and eventual dismissal

19:19 - The rigged consolidated hearing and Darren Gibson

27:34 - Dr. DiGiorgio on the medical training dismissal system

29:51 - Why Kevin still believes in the broader legal system

33:00 - What Kevin has been building since dismissal

36:00 - Using AI to analyze the Epstein files

40:10 - The messiness of large health data sets

46:00 - Immigration policy data analysis

49:06 - Medicaid fraud and the limits of legal definitions

56:20 - Advice to physicians on AI

01:03:10 - The future of health policy research in the AI era

@anish_koka and @drdigiorgio

@drsloungepod

🎧 Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1489323962

🎧 Spotify: https://open.spotify.com/show/7vE4aCMpVHnSGwuOHiGVLp

▶️ YouTube: https://www.youtube.com/@TheDoctorsLounge

Resources:

Kevin Bass's case documentation site: https://case.kevinnbass.com

Kevin Bass on Substack: https://www.kevinnbass.com

Kevin Bass on X: @kevinnbass

Kevin's original Newsweek op-ed (Jan. 2023): https://www.newsweek.com/its-time-scientific-community-admit-we-were-wrong-about-coivd-it-cost-lives-opinion-1776630

Kevin's Epoch Times essay on his dismissal: https://www.theepochtimes.com/opinion/how-my-medical-school-scandalously-dismissed-me-5580841

Dr. Anish Koka and Dr. Anthony DiGiorgio open with the little-known medical story behind the death of the Shah of Iran — how Mohammed Reza Pahlavi came to be operated on in Cairo in 1980 by legendary cardiovascular surgeon Michael DeBakey, and how the "comforting explanation" bias may have contributed to his death from a post-operative abscess rather than his underlying cancer. The case, drawn from a piece by Dr. Li Zhao (NYU Langone), launches a broader conversation about anchoring bias in medicine and the cognitive traps all clinicians face. From there, the hosts turn to the quality metric industrial complex — MIPS, the new low back pain ambulatory model threatening a 12% Medicare penalty for spine surgeons, the hospital readmission program's documented mortality spike, and how 2,266 CMS metrics are costing billions while failing patients. They close with a NEJM perspectives piece from Harvard Business School's Leemore Daphne on health insurance consolidation and her surprisingly free-market prescriptions for reform.

Chapters

00:00 Introduction

02:00 The Shah of Iran — Political Background

03:45 The Shah's Leukemia and Michael DeBakey's 1980 Surgery

06:30 A Spleen the Size of a Football

08:00 The Decision Not to Drain — And Its Consequences

10:00 The Comforting Explanation Bias

12:30 Subspecialization Matters — The Most Famous Surgeon Isn't Always the Right One

14:45 Anchoring Bias in Clinical Medicine

17:00 Modern Imaging and Residents as Checks on Bias

18:30 Surgeons, Complications, and the M&M Conference

21:00 Segue: Judging Doctors by Stats

22:30 The Origins of Quality Metrics — Donabedian 1966

24:00 MIPS and How It Actually Works

26:00 The New Back Pain Ambulatory Specialty Model — A 12% Penalty

28:00 Evidence That Metrics Harm Patients: Hospital Readmission Reduction Program

30:30 Obstetrics and the C-Section Penalty

31:30 Press Ganey and the Cafeteria Problem

33:00 Risk Adjustment Gaming — 40% Margin Increase from Coder Rounding

38:00 2,266 Metrics and 108,000 Person-Hours at Johns Hopkins

40:00 Why Doctors Leave Medicare

42:00 What Good Metrics Could Look Like — Dr. DiGiorgio's JAMA Proposal

44:00 Health Insurance Consolidation — NEJM Perspectives

50:30 FDA, Vinay Prasad, and the WSJ Retraction

55:00 Next Week: Kevin Bass

Subscribe to The Doctor's Lounge: Apple Podcasts | Spotify | YouTube Follow the Show: X: @DrsLoungePod Co-hosts: @anish_koka | @drdigiorgio

Guest: Ali Mortazavi | CEO, Tangram Therapeutics (formerly E-Therapeutics), London, UK

Episode Summary:

Ali Mortazavi is not your typical biotech CEO. A computer scientist by training, former professional chess player, and veteran of financial markets, he invested in an RNAi company in 2012 — and then, by his own admission, made the crazy decision to become its CEO with zero background in biology, chemistry, or medicine.

What followed is a 14-year education in the brutal realities of drug development — and a front-row seat to the AI revolution now reshaping it. In this wide-ranging conversation, Mortazavi draws on his extraordinary personal story (fleeing revolutionary Iran as a child, arriving in London unable to speak English, rising through chess and finance) to offer a uniquely cross-disciplinary perspective on why biotech is stuck in a me-too loop, why the incentive system is the real bottleneck, and where AI is — and isn't — changing the game.

0:00 - Introduction & Ali's Background

1:07 - The Iranian Revolution at Nine Years Old

4:44 - Fleeing Iran, Arriving in London

6:38 - The Refugee Experience and Starting Over

7:49 - Computer Science in 1990

9:53 - Becoming a Professional Chess Player

11:06 - The Vishwanathan Anand Moment

13:17 - From Chess to Finance to Biotech CEO

14:44 - The Gleevec Illusion and the Reality of Drug Development

16:07 - Jay Bhattacharya, Reproducibility, and the PubMed Button

18:18 - LLMs as Scientific Compression Systems

20:15 - Why LLMs Give "The Average Answer" — The Co-Pilot Model

23:44 - Vibe Coding and the Explosion of Code

25:36 - AI Won't Replace 10x Coders — It Will Replace 90 of 100

26:16 - The GalNAC Case Study: 35 Years of Forgotten Innovation

31:10 - The Me-Too Algorithm and Biotech VC Incentives

34:40 - GLP-1s: Another 30 Years of Sitting Around

35:26 - The FDA, the XBI, and the Current Regulatory Landscape

40:43 - Can Politics Fix the Incentive System?

42:09 - Why Past Progress Happened Without AI

44:24 - Medical Ethics, Experimentation, and the Innovation Tradeoff

48:34 - Biotech Is Archaic: The Preclinical De-Risking Problem

50:05 - No Animal Model Actually Works

52:16 - Over-Regulation vs. Just Plain Hard

53:00 - The US Market as the Global Subsidy Engine

54:05 - China: Wake-Up Call, Not Innovator

56:25 - The London Market: "Don't Call It a Market"

58:52 - AI-Native Biotechs: Too Soon to Tell

59:36 - Where AI Works: Information. Where It Doesn't: Physics.

1:01:29 - Tangram Therapeutics and Libra OS

1:04:25 - The Future: SaaS Collapse, Medicine Returns to Fundamentals

1:07:36 - Closing: Hope, Broken Glass, and Early Adoption

Subscribe to The Doctor's Lounge: Apple Podcasts | Spotify | YouTube | RSS

Follow the Show: X: @DrsLoungePod

Follow the Guest: X: @AAMortazavi

Co-hosts: @anish_koka | @drdanchoi | @dutchrojas | @sdixitmd | @drdigiorgio

In this conversation, Dr. Mary Talley Bowden shares her experiences as an independent physician during the COVID-19 pandemic, detailing her courageous battle against health systems and the Texas Medical Board. She discusses the challenges faced by healthcare professionals, the impact of politics on medical practices, and the importance of patient care and medical freedom. Dr. Bowden emphasizes the need for changes in healthcare policies, including the repeal of mandates and the promotion of alternative treatments like ivermectin. Her personal philosophy and motivation to fight for her patients shine through as she navigates the complexities of the healthcare system.

Chapters

00:00 Introduction to Dr. Mary Talley Bowden

02:17 Dr. Bowden's Courageous Battle Against Health Systems

06:01 The Role of Telemedicine and Ivermectin in COVID Treatment

11:37 Legal Battles and Hospital Privileges

17:03 The Texas Medical Board and Its Controversies

22:21 Political Dynamics in Texas Healthcare

27:22 The Future of Independent Medicine

32:19 The Impact of COVID Vaccines on Patients

37:26 Ethical Concerns and Medical Mandates

40:40 Critique of Public Health Figures

46:03 The Role of Independent Physicians

50:58 Future of Healthcare and Patient Empowerment

About Dr. Mary Talley Bowden:

Dr. Mary Talley Bowden is a Stanford-trained ENT physician running a solo, third-party-free practice in Houston, Texas. She became nationally known during COVID for continuing to see patients, offering early treatment, and publicly opposing vaccine mandates. She is currently in ongoing litigation with both Houston Methodist and the Texas Medical Board.

Subscribe to The Doctor's Lounge: Apple Podcasts | Spotify | YouTube | RSS

Follow the Show: X: @DrsLoungePod

Co-hosts: @anish_koka | @drdanchoi | @dutchrojas | @sdixitmd |

Episode Title: The Medicaid Data Dump: $1.7 Billion in Billing From Shell Companies and Why Nobody Stopped It

Guest: Samir Unni | Biomedical Engineer, former Palantir healthcare data lead, currently working on federal data modernization efforts

Chapters

00:00 Introduction and Technical Difficulties

02:47 Reflections on Jay Bhattacharya's Insights

06:04 Navigating Polarization in Science

08:50 Moderna's Flu Vaccine Controversy

11:56 Understanding the FDA's Refusal to File

14:58 The Medicaid Data Dump and Its Implications

17:50 Duplicate Payments in Medicaid

20:59 The Role of Transparency in Healthcare

24:01 Home Health Services and Fraud Risks

42:57 Understanding Fraud in Government Billing

46:51 Political Ramifications of Home Health Agencies

50:53 Analyzing Data for Fraud Detection

56:30 Incentives and Accountability in Healthcare

01:01:52 The Role of Technology in Fraud Prevention

01:12:32 Legislative Solutions to Healthcare Fraud

Resources Mentioned:

• Samir Unni's viral Medicaid data thread (@SamirUnni on X)
• CMS TMSIS Medicaid provider-level data release
• Anish Koka's deep dive on Fluarix clinical efficacy
• HHS Office of Inspector General excluded individuals/entities list
• Dr. Mandrola's posts on the Moderna/FDA controversy
• Alex Berenson's report on autism behavioral therapy billing trends

About Samir Unni:

Samir Unni is a biomedical engineer who has spent over a decade working at the intersection of healthcare and data analytics. He previously served as a lead at Palantir working with government and healthcare organizations, and is now focused on modernizing how the federal government leverages AI and data tools to identify waste and fraud in public health programs.

Subscribe to The Doctor's Lounge: Apple Podcasts | Spotify | YouTube | RSS

Follow the Show: X: @drsloungepod

Co-hosts: @anish_koka | @drdanchoi | @dutchrojas | @sdixitmd | @DrDiGiorgio

In this engaging conversation, Dr. Jay Bhattacharya discusses his unique perspective as a health economist and the impact of his training on his approach to public health, particularly during the COVID-19 pandemic. He reflects on the Great Barrington Declaration, the importance of dissent in science, and the need for reform within the NIH to foster innovation and address the replication crisis in research. Dr. Bhattacharya emphasizes the necessity of a culture shift in science, advocating for transparency and rigorous inquiry into public health issues, including vaccines and chronic diseases.

Takeaways

Dr. Bhattacharya's background in economics shapes his approach to health policy.

The COVID-19 pandemic highlighted the importance of considering trade-offs in public health decisions.

Dissent in science is crucial for progress and innovation.

The Great Barrington Declaration challenged the prevailing public health narrative during the pandemic.

The NIH must adapt to foster a culture of questioning and innovation.

Addressing the replication crisis is essential for restoring trust in scientific research.

Public health responses must be transparent and trustworthy to gain public confidence.

Raising the evidentiary bar for vaccines is necessary to ensure safety and efficacy.

The NIH's role in funding research should focus on improving health outcomes.

A second scientific revolution is needed to shift the power dynamics in research.

Titles

Navigating Public Health: Insights from Dr. Jay Bhattacharya

The Economics of Health Policy: A Conversation with Dr. Bhattacharya

Chapters

00:00 Introduction to Dr. Jay Bhattacharya

03:18 The Influence of Economics on Health Policy

06:23 Unique Perspectives During the COVID-19 Pandemic

10:12 The Role of Authority in Public Health Decisions

13:08 The Great Barrington Declaration and Its Impact

16:27 Challenges to Scientific Consensus

19:08 Leading the NIH: An Economic Perspective

22:33 Addressing the Replication Crisis in Science

36:56 Addressing Scientific Stagnation and Replication Crisis

43:42 Fostering a Culture of Dissent in Science

52:56 Setting Research Priorities for Public Health

59:58 Navigating Vaccine Safety and Public Trust

Subscribe to The Doctor's Lounge: Apple Podcasts | Spotify | YouTube | RSS

Follow the Show: X: @drsloungepod

Co-hosts: @anish_koka | @drdanchoi | @dutchrojas | @sdixitmd | @DrDiGiorgio